PeerVoice Oncology & Haematology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 19m. Bisher sind 263 Folge(n) erschienen. Dies ist ein wöchentlich erscheinender Podcast.

Gesamtlänge aller Episoden: 4 days 13 hours 29 minutes

subscribe
share






Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals


Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals


share








 2022-10-19  18m
 
 

Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC


Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC


share








 2022-10-04  1h20m
 
 

Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice


Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice


share








 2022-10-03  24m
 
 

Managing Cytopenic Myelofibrosis: New and Emerging Therapies and Who May Benefit


Managing Cytopenic Myelofibrosis: New and Emerging Therapies and Who May Benefit


share








 2022-09-30  18m
 
 

Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC


Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC


share








 2022-09-30  27m
 
 

Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC


Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC


share








 2022-09-20  24m
 
 

Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions


Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions


share








 2022-09-07  20m
 
 

Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care


Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care


share








 2022-08-31  55m
 
 

Question Time: Applying New Therapies for the Management of mTNBC


Question Time: Applying New Therapies for the Management of mTNBC


share








 2022-08-25  38m
 
 

New Biomarkers, New Targets in Advanced NSCLC


New Biomarkers, New Targets in Advanced NSCLC


share








 2022-08-17  20m